Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Biogen raises Facet offer to $17.50 per share
Yahoo/AP
Thursday, December 3, 2009 - 5:40pm
tags:
Facet Biotech, Biogen Idec, M&A
Should Amgen Buy Human Genome Sciences?
Forbes
Thursday, December 3, 2009 - 5:39pm
tags:
Human Genome Sciences, Amgen, M&A
Cubist Pharma says reviewers found more deaths in patients taking its drug; Dyax stock skids
Yahoo/AP
Thursday, December 3, 2009 - 5:38pm
tags:
Dyax, Cubist Pharmaceuticals
Pharma Spending On Detailing Is Up: CBO
Pharmalot
Thursday, December 3, 2009 - 3:17pm
tags:
detailing, pharm reps, drug reps, drug marketing
No Holiday For Biopharma P & A
CNBC
Thursday, December 3, 2009 - 3:10pm
tags:
partnerships, M&A, Pfizer, Protalix BioTherapeutics, Targacept, AstraZeneca, Merck, Amgen, GSK, Human Genome Sciences
Novartis buy seen likely after Alcon shares gain
Reuters
Thursday, December 3, 2009 - 11:22am
tags:
Novartis, M&A, Alcon, Nestle
Drug reps or DTC? Congress checks it out
Fierce Pharma
Thursday, December 3, 2009 - 11:20am
tags:
congress, DTC, drug reps
Consumer safety group seeks FDA ban of weight loss pill Meridia, citing heart attack risks
Yahoo/AP
Thursday, December 3, 2009 - 11:19am
tags:
Meridia, weight loss, side effects, Abbott Laboratories, Public Citizen
Behind the Business: 3 Questions for Vical
Motley Fool
Thursday, December 3, 2009 - 11:18am
tags:
Vical
Isis Pharmaceuticals Adds Two New Drugs to Development Pipeline
Yahoo
Thursday, December 3, 2009 - 9:59am
tags:
pipelines, Isis Pharmaceuticals
Drug stocks gain; Endo shares retreat
Marketwatch
Thursday, December 3, 2009 - 9:58am
tags:
Endo, drug stocks, Aveed, testosterone
War Stories III: Vermillion -- Up 215,000% -- Plans Escape from Bankruptcy
BNET Pharma
Thursday, December 3, 2009 - 9:57am
tags:
Vermillion, bankruptcy
Fed Probe Into Johnson & Johnson Reaches Zero Hour
Pharmalot
Thursday, December 3, 2009 - 9:51am
tags:
JNJ, Scios, Natrecor
Gilead-Glaxo Deal Targets Asia
Yahoo/Zacks.com
Thursday, December 3, 2009 - 9:45am
tags:
Gilead Sciences, Asia, GSK, partnerships, Viread, Bristol-Myers Squibb
Novartis cleared by EC for a COPD treatment
Marketwatch
Thursday, December 3, 2009 - 9:43am
tags:
COPD, Novartis, Europe
Cephalon sues Teva over sleep drug Nuvigil
Yahoo/AP
Thursday, December 3, 2009 - 8:54am
tags:
Teva Pharmaceuticals, patents, NUVIGIL, generics
Vertex Raising Money -- Again!
TheStreet.com
Thursday, December 3, 2009 - 8:53am
tags:
Vertex Pharmaceuticals, stock offering
Sanofi warning on antidepressant Norpramin
Yahoo/Reuters
Thursday, December 3, 2009 - 8:52am
tags:
antidepressants, Norpramin, warning, Sanofi
AstraZeneca, Targacept to develop depression drug
Marketwatch
Thursday, December 3, 2009 - 8:50am
tags:
AstraZeneca, depression, Targacept
Lilly Urged Zyprexa Use Without Proper Diagnosis
BNET Pharma
Wednesday, December 2, 2009 - 9:31pm
tags:
Eli Lilly, Zyprexa

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.